https://biopharma360.com/promed-pharma-acquires-spinethera-manufacturing-capabilities-and-an-option-to-license-intellectual-property/2024-04-05T08:34:09+00:00https://biopharma360.com/ai-helps-pharma-find-new-drugs-but-imperils-lucrative-patents/2024-04-05T08:21:22+00:00https://biopharma360.com/amylyx-pharma-to-remove-als-drug-from-us-canada-markets/2024-04-05T08:33:14+00:00https://biopharma360.com/innovationrx-tarsus-pharmaceuticals-takes-aim-at-disease-causing-bugs/2024-06-24T14:25:54+00:00https://biopharma360.com/fda-panel-makes-the-call-on-much-anticipated-alzheimers-drug-donanemab/2024-06-24T14:16:08+00:00https://biopharma360.com/https-www-forbes-com-councils-forbestechcouncil-2024-06-11-the-future-of-medicine-how-ai-is-revolutionizing-pharma/2024-09-10T23:00:32+00:00